Navigation Links
Quanticel Pharmaceuticals Enters Into Strategic Cancer Drug Discovery Collaboration With Celgene Corporation
Date:11/4/2011

his scientific collaboration and this business model as an innovative approach with high potential to advance the delivery of impactful cancer drugs to patients in need."

The collaboration utilizes an innovative funding structure between Quanticel, Celgene and Versant Ventures.  Versant and Celgene have worked together to capitalize Quanticel at an early juncture, providing Versant with a strategic partner and potential acquirer, and Celgene with early and exclusive access to an R&D engine capable of fostering breakthrough therapies for patients at an accelerated pace.

"Aligning our financing strategy to create a start-up that supports the needs of a pre-eminent global biopharmaceutical company such as Celgene should build even greater value and liquidity than the traditional biotech venture approach," said Bradley Bolzon, Ph.D., Managing Director, Versant Ventures.

About Quanticel Pharmaceuticals

Quanticel Pharmaceuticals is a private, independent drug discovery company committed to creating breakthrough medicines for the treatment of cancer and other life-threatening diseases.  Quanticel's proprietary platform for the single-cell genomic analysis of human cancer is based on the work of company founders and Stanford professors Stephen Quake and Michael Clarke.  Quanticel brings together pioneering academic serial entrepreneurs, proven industry talent who have produced marketed drugs and high-value liquidity events, and top-tier Bay Area investor Versant Ventures.  The Company is headquartered in San Francisco, California.  For more information, please visit the Company's website at www.quanticel.com.

About Celgene

Celgene Corporation is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of innovative therapies for the treatment of cancer and inflammatory diseases through gene
'/>"/>

SOURCE Quanticel Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... Report Details  New ... companies  What does the future hold for ... Visiongain,s brand new report shows you potential revenues to ... Our 242-page report provides 185 tables, charts, and ... and the future market prospects. Our new study lets ...
(Date:3/27/2015)... 2015 The International Myeloma Foundation (IMF) – ... working toward prevention and a cure – today commended ... federal resolution (H. Res. 174) that supports the designation ... Myeloma Awareness Month." Currently there are more ... than 110,000 new cases are diagnosed yearly, according to ...
(Date:3/27/2015)... 27, 2015 RnRMarketResearch.com adds ... market research report of 52 pages with latest ... intelligence library. The report "Visceral Pain - Pipeline ... therapeutic development for Visceral Pain, complete with comparative ... target, mechanism of action (MoA), route of administration ...
Breaking Medicine Technology:Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 2Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 3Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 4Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 5Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 6Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 7The International Myeloma Foundation (IMF) Secures the Introduction of a Federal Resolution Recognizing March 2015 as "National Multiple Myeloma Awareness Month" 2Visceral Pain Pipeline Review H1 2015 Market Research Report 2Visceral Pain Pipeline Review H1 2015 Market Research Report 3Visceral Pain Pipeline Review H1 2015 Market Research Report 4
... MEETING, Pa., Feb. 10 Genaera Corporation (Nasdaq: ... clinical data for trodusquemine (MSI-1436), the first-in-class, highly selective ... the treatment of type 2 diabetes and obesity. ... data from the first of three cohorts in an ...
... A new study published today claiming that multivitamin ... risk of mortality fails to take into account important ... health claims are regulated by the U.S. Food and ... published in the February 9 issue of Archives ...
Cached Medicine Technology:Genaera Presents Preliminary Phase 1b Data for Trodusquemine (MSI-1436) 2Genaera Presents Preliminary Phase 1b Data for Trodusquemine (MSI-1436) 3Evidence Lacking in Multivitamin Study of Women's Risk of Cancer, Heart Disease or Death, Says Natural Products Association 2
(Date:3/27/2015)... Dallas, TX (PRWEB) March 27, 2015 ... Landscape – Germany” is an essential source of ... and reimbursement landscape in Germany. Germany’s increasingly elderly ... drivers of its pharmaceutical market. In 2013, the ... expected to increase at Compound Annual Growth Rate ...
(Date:3/27/2015)... and LONDON, UK (PRWEB) March 27, 2015 ... DrugDev SiteStart Melissa (Liss) Easy was named to the ... The 40 Under 40 list spotlights 40 dynamic, up-and-coming ... professional accomplishments and community involvement. Winners are honored at ... special supplement of the Philadelphia Business Journal. , Lyn ...
(Date:3/27/2015)... USA (PRWEB) March 27, 2015 According ... rates of newborns born with Neonatal Abstinence Syndrome (NAS) ... NAS will undergo the painful withdrawal process for a ... body tremors, excessive crying, diarrhea, and vomiting. The condition ... undergoing drug and alcohol addiction treatment (and employing medically ...
(Date:3/27/2015)... (PRWEB) March 27, 2015 California’s ongoing ... blizzards in Boston and the United States Northeast, are ... Earth warming global atmosphere is creating changes in the ... historical climatologist and former NASA researcher, speaking on the ... result is not only a warmer and dryer global ...
(Date:3/27/2015)... To address their number one lawn care ... year filming this video to explain the complicated dynamics between ... it's often expected to thrive in, be it in dense ... to survive. Anytime a sun-loving plant is put in the ... Many homeowners try to amend this issue by applying large ...
Breaking Medicine News(10 mins):Health News:Germany Healthcare, Regulatory and Reimbursement Landscape Market Research Report Available at RnRMarketResearch.com 2Health News:Germany Healthcare, Regulatory and Reimbursement Landscape Market Research Report Available at RnRMarketResearch.com 3Health News:Germany Healthcare, Regulatory and Reimbursement Landscape Market Research Report Available at RnRMarketResearch.com 4Health News:DrugDev Founder Melissa Easy is 2015 Philadelphia Business Journal 40 Under 40 Honoree 2Health News:In Florida Only 10% of Pregnant Mothers Are Referred to Drug Rehab Despite Testing Positive for Narcotics 2Health News:California Drought, Boston Blizzards Both Attributed to Global Climate Change Reports Climatologist to Fresh Water Advocate 2Health News:California Drought, Boston Blizzards Both Attributed to Global Climate Change Reports Climatologist to Fresh Water Advocate 3Health News:For Spring Turf Planting Season, Super-Sod Created a New How-To Video Entitled "Two Views on Shade and Turf" 2
... campaign had failed to hand out morning-after pills to ... pregnancies.// The campaign has neither reduced conception nor abortion ... accused of fuelling record levels of sexually transmitted diseases. ... the Government has spent ? 138million on its Teenage ...
... a public awareness campaign warning people against undertaking ... ,The surgeons have cautioned that undergoing ... and chemical peels, which if performed by improperly ... even death in some cases. ...
... marks the rapid increase in esophageal cancer cases in the US. ... Only 16 % or around 2,200, of the 14,000-esophageal cancer cases ... ,There has been a 6-fold annual rise in the number ... experts. Rise in obesity cases has been the major cause. ...
... FDA, an epidemic of E. coli that has left one ... be associated with bagged fresh spinach.// ,"The FDA ... time and that any individuals who believe they may have ... their health care provider," Dr. David Acheson, head of the ...
... out if metastasis from the eye cancer will make its ... University School of Medicine in St. Louis have developed a ... might spread to the liver, where it could quickly transform ... opinion that the molecular screening test might one day help ...
... given ?5,000 to retrain themselves to work ... Andy Kerr said that the Scottish Executive ... years on this plan.// ,This plan ... trained outside Europe and are not licensed ...
Cached Medicine News:Health News:Government Failed to Prevent Rising Teen Pregnancies 2Health News:Government Failed to Prevent Rising Teen Pregnancies 3Health News:Campaign Against Cosmetic Surgeries Performed By Less-Skilled Non-physicians Launched 2Health News:Rise in Esophageal Cancer is emphasized by Richards’ deat 2Health News:Metastasis Of Ocular Melanoma To Liver Can Now Be Calculated 2Health News:Metastasis Of Ocular Melanoma To Liver Can Now Be Calculated 3Health News:Metastasis Of Ocular Melanoma To Liver Can Now Be Calculated 4
... (IGF-I or somatomedin C) is a 7.6 kDa ... as a potent mitogen of cellular proliferation, exerting ... In the circulation, IGF-I is bound to IGF-binding ... of IGF-I by modulating the interaction of IGF-I ...
... name from its first known site of ... of PSA circulates bound to anti-chymotrypsin (PSA-ACT) ... PSA are elevated in patients with prostate ... [1-3]. In addition, PSA serum levels appear ...
Inquire...
The design of this table top is based on advanced functionality for specific urological requirements. This composite product sets a new standard for urological imaging....
Medicine Products: